Related content

Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant

By Tachibana Takayoshi  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1318-1320

Informa Healthcare

Access to resources Recommend Favorite

Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report

By      

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 422-424

Spandidos Publications

Access to resources Recommend Favorite

Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine

By Breccia Massimo  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1786-1787

Informa Healthcare

Access to resources Recommend Favorite

Lymphocyte recovery on day 100 after allogeneic hematopoietic stem cell transplant predicts non-relapse mortality in patients with acute leukemia or myelodysplastic syndrome

By Yamamoto Wataru   Ogusa Eriko   Matsumoto Kenji   Maruta Atsuo   Ishigatsubo Yoshiaki   Kanamori Heiwa  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1113-1118

Informa Healthcare

Access to resources Recommend Favorite

Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors

By Kaplan Henry   Malmgren Judith   Li Christopher   Calip Gregory  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 629-636

Springer Publishing Company

Access to resources Recommend Favorite